Icosavax, Inc. (ICVX) has 18 open-market insider trades by 13 insiders since 2021. The most active filer is Niranjan Kanesa-thasan.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rajeev M. Shah | Dir10% Owner | — | 1 | $40.0M | 2021-08-02 |
| Niranjan Kanesa-thasan | — | — | 3 | $3.6M | 2024-02-19 |
| Qiming U.S. Healthcare Fund II, L.P. | — | — | 1 | $3.3M | 2021-08-02 |
| NanoDimension III, L.P. | — | — | 1 | $2.0M | 2021-08-02 |
| Terry P. Gould | Dir | — | 1 | $2.0M | 2021-08-02 |
| RA Capital Healthcare Fund LP | Dir10% Owner | — | 1 | $1.6M | 2024-02-19 |
| Sanofi | 10% Owner | — | 1 | $1.0M | 2021-08-02 |
| Adam K. Simpson | CEO | — | 2 | $678K | 2024-02-19 |
| Mark McDade | Dir | — | 1 | $600K | 2024-02-19 |
| Douglas Holtzman | CSO | — | 2 | $500K | 2023-07-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Adam K. Simpson | CEO | Sell | $229K | 2024-02-01 |
| Adam K. Simpson | CEO | Sell | $235K | 2024-01-02 |
| Adam K. Simpson | CEO | Sell | $3.3M | 2023-12-20 |
| Cassia Cearley | — | Sell | $245K | 2023-12-20 |
| Thomas Joseph Russo | CFO | Sell | $470K | 2023-12-20 |
| Niranjan Kanesa-thasan | — | Sell | $367K | 2023-12-20 |
Companies that share insiders with ICVX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Cassia Cearley | — | Sell | $280K | 2023-12-13 |
| Niranjan Kanesa-thasan | Chief Medical Officer | Sell | $29K | 2023-07-31 |
| Adam K. Simpson | CEO | Sell | $209K | 2023-07-31 |
| Cassia Cearley | Chief Business Officer | Sell | $17K | 2023-07-31 |
| Thomas Joseph Russo | CFO | Sell | $27K | 2023-07-31 |
| Douglas Holtzman | CSO | Sell | $269K | 2023-07-03 |
| Cassia Cearley | — | Sell | $100K | 2023-05-23 |
| Douglas Holtzman | CSO | Sell | $247K | 2023-04-03 |
| Cassia Cearley | Chief Business Officer | Sell | $39K | 2023-03-06 |